Evaluation Of The Effect Of PF-05089771 On The Metabolism Of Multiple Cytochrome P450 And OATP1B1 Transporter Substrates
Phase of Trial: Phase I
Latest Information Update: 15 Jan 2014
At a glance
- Drugs PF 5089771 (Primary)
- Indications Pain
- Focus Pharmacokinetics
- Sponsors Pfizer
- 15 Jan 2014 Status changed from recruiting to completedas reported by ClinicalTrials.gov record.
- 10 Sep 2013 New trial record
- 01 Sep 2013 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.